Literature DB >> 17302888

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

C Sander1, H McShane.   

Abstract

Tuberculosis (TB) continues to be a major global health disaster, despite the widespread use of BCG and effective drug therapies. The development of an efficacious new TB vaccine would be an important component of disease control in the future. Many approaches are being utilised to enhance understanding of the requirements of a successful vaccine. Numerous vaccines are being designed and assessed in a series of animal models, with a few progressing to clinical trials. Here, the steps involved in the development and evaluation of TB vaccines will be discussed, including description of the most frequently used animal models and the processes involved in advancing vaccines to phase III trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302888      PMCID: PMC1810501          DOI: 10.1111/j.1365-2249.2006.03306.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  106 in total

1.  The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4.

Authors:  J Turner; A A Frank; J V Brooks; M Gonzalez-Juarrero; I M Orme
Journal:  Exp Gerontol       Date:  2001-03       Impact factor: 4.032

2.  Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.

Authors:  D Elias; H Akuffo; C Thors; A Pawlowski; S Britton
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 3.  Natural history and spectrum of disease in adults with HIV/AIDS in Africa.

Authors:  A D Grant; G Djomand; K M De Cock
Journal:  AIDS       Date:  1997       Impact factor: 4.177

Review 4.  New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.

Authors:  Madhukar Pai; Shriprakash Kalantri; Keertan Dheda
Journal:  Expert Rev Mol Diagn       Date:  2006-05       Impact factor: 5.225

Review 5.  Advances in tuberculosis vaccine strategies.

Authors:  Yasir A W Skeiky; Jerald C Sadoff
Journal:  Nat Rev Microbiol       Date:  2006-06       Impact factor: 60.633

6.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

7.  Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis.

Authors:  P F Barnes; V Mehra; B Rivoire; S J Fong; P J Brennan; M S Voegtline; P Minden; R A Houghten; B R Bloom; R L Modlin
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

8.  Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

Authors:  F Altare; D Lammas; P Revy; E Jouanguy; R Döffinger; S Lamhamedi; P Drysdale; D Scheel-Toellner; J Girdlestone; P Darbyshire; M Wadhwa; H Dockrell; M Salmon; A Fischer; A Durandy; J L Casanova; D S Kumararatne
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

9.  Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.

Authors:  Abebech Demissie; Eliane M S Leyten; Markos Abebe; Liya Wassie; Abraham Aseffa; Getahun Abate; Helen Fletcher; Patrick Owiafe; Philip C Hill; Roger Brookes; Graham Rook; Alimuddin Zumla; Sandra M Arend; Michel Klein; Tom H M Ottenhoff; Peter Andersen; T Mark Doherty
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.

Authors:  R E Weir; P E M Fine; B Nazareth; S Floyd; G F Black; E King; C Stanley; L Bliss; K Branson; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more
  9 in total

1.  Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 2.  How B cells shape the immune response against Mycobacterium tuberculosis.

Authors:  Paul J Maglione; John Chan
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

3.  Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.

Authors:  Susan L Baldwin; Sylvie Bertholet; Maria Kahn; Irina Zharkikh; Gregory C Ireton; Thomas S Vedvick; Steven G Reed; Rhea N Coler
Journal:  Vaccine       Date:  2009-03-26       Impact factor: 3.641

Review 4.  Prime-boost approaches to tuberculosis vaccine development.

Authors:  Neha Dalmia; Alistair J Ramsay
Journal:  Expert Rev Vaccines       Date:  2012-10       Impact factor: 5.217

5.  Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Authors:  Gillian F Black; Bonnie A Thiel; Martin O Ota; Shreemanta K Parida; Richard Adegbola; W Henry Boom; Hazel M Dockrell; Kees L M C Franken; Annemiek H Friggen; Philip C Hill; Michel R Klein; Maeve K Lalor; Harriet Mayanja; Gary Schoolnik; Kim Stanley; Karin Weldingh; Stefan H E Kaufmann; Gerhard Walzl; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

6.  Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K.

Authors:  Kee Woong Kwon; Woo Sik Kim; Hongmin Kim; Seung Jung Han; Mi-Young Hahn; Jong Seok Lee; Ki Taek Nam; Sang-Nae Cho; Sung Jae Shin
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

Review 7.  Confronting the scientific obstacles to global control of tuberculosis.

Authors:  Douglas B Young; Mark D Perkins; Ken Duncan; Clifton E Barry
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 8.  The Role of Nitroreductases in Resistance to Nitroimidazoles.

Authors:  Carol Thomas; Christopher D Gwenin
Journal:  Biology (Basel)       Date:  2021-05-01

9.  A putative nitroreductase from the DosR regulon of Mycobacterium tuberculosis induces pro-inflammatory cytokine expression via TLR2 signaling pathway.

Authors:  Vidyullatha Peddireddy; Sankara Narayana Doddam; Insaf A Qureshi; Priyadarshini Yerra; Niyaz Ahmed
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.